We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo ADLM 2026 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

QuidelOrtho Demonstrates Automated, Sample-To-Result, Multiplex RT-PCR Testing Platform at Medlab Middle East 2023

By LabMedica International staff writers
Posted on 08 Feb 2023
Image: QuidelOrtho is demonstrating how to improve workflow and respond more flexibly and quickly to patient needs (Photo courtesy of QuidelOrtho)
Image: QuidelOrtho is demonstrating how to improve workflow and respond more flexibly and quickly to patient needs (Photo courtesy of QuidelOrtho)

At Medlab Middle East 2023, QuidelOrtho Corporation (San Diego, CA, USA) is showcasing for the first time the benefits of the combined organization’s consolidated portfolio of world-class technologies and platforms, through expanded access to clinical chemistry, immunoassay, molecular diagnostics, immunohematology, donor screening, and point-of-care diagnostics offerings.

At the QuidelOrtho booth, the focus is on the Savanna automated, sample-to-result, multiplex RT-PCR testing platform that performs real-time Polymerization Chain Reaction (PCR) tests by using the Savanna instrument and Savanna assay cartridges. This evolutionary multiplex molecular platform enables professional customers to analyze up to 12 pathogens or targets, plus controls, from a single assay run in less than 30 minutes. After inserting the assay cartridge, the instrument performs sample and reagent preparation, nucleic acid extraction and amplification, real-time detection of RNA or DNA target sequence, and qualitative or quantitative result interpretation from a variety of sample types. The Savanna system is intended to aid in the diagnosis of the related diseases.

QuidelOrtho is also demonstrating the Savanna RVP4 Assay (Respiratory Viral Panel-4), a rapid, multiplexed nucleic acid test intended for use with the Savanna instrument for the simultaneous qualitative detection and differentiation of influenza A (Flu A), influenza B (Flu B), respiratory syncytial virus (RSV), and SARS-CoV-2 RNA isolated from human nasal or nasopharyngeal swabs in media obtained from patients with signs and symptoms of respiratory tract infection. The in vitro diagnostic test is intended to aid in the differential diagnosis of infections with these viruses. The Savanna RVP4 Assay comes in a fully integrated cartridge that is stable at room temperature.

Related Links:
QuidelOrtho Corporation 

Visit expo >
Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
Online QC Software
Acusera 24•7
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Automated Coagulation Analyzer
Hemolumi H6

Latest Medlab 2023 News

Channels

Clinical Chemistry

view channel
New Machine-Learning Equation Improves LDL Cholesterol Assessment
Blood Biomarker May Signal Cognitive Decline Risk a Decade Before Symptoms
Ultrasensitive Biosensor Detects Early Liver Fibrosis from Blood
Image: Workflow of 19 F NMR–based serum amino acid profiling and data analysis. Serum samples collected from CRC patients were subjected to fluorine-labeling–based amino acid detection followed by 19 F NMR spectroscopy. Quantified amino acid data were processed using ratio-based normalization and multivariate analyses to characterize stage-specific metabolic patterns and construct machine learning models for prognostic risk prediction. (Photo courtesy of KAIST)

Preoperative Blood Test Predicts Colorectal Cancer Recurrence and Metastasis

Cancer cells require large amounts of nutrients to grow and proliferate, and amino acids support key processes including protein formation, energy production, and DNA synthesis. Colorectal cancer is marked... Read more

Molecular Diagnostics

view channel
New Test Delivers Four Prenatal Genetic Screens from One Blood Sample
Multiplex PCR Test Differentiates Four Causes of Ulcerative Skin Lesions
Blood Test Guides Patient Selection for Radiopharmaceutical Therapy in Prostate ...
Image: Visual Abstract (Seemesh Bhaskar et al., Point of care molecular cancer diagnostics, Lab on a Chip, 2026. DOI: 10.1039/d5lc01014d)

Point-of-Care Molecular Technology Promises Transformative Shift in Oncology

Delays in obtaining molecular test results can hinder timely oncology decisions and widen disparities for patients far from centralized laboratories. Prolonged waits may also heighten anxiety and increase... Read more

Hematology

view channel
New Marker Helps Detect Aggressive Multiple Myeloma Earlier
New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer
AI Decision Support System Guides Treatment Selection for Complex Blood Cancers
Image: ARUP CLARISPECT Multiple Myeloma MRD by Spectral Flow Cytometry characterizes small neoplastic populations with greater sensitivity than conventional flow cytometry while requiring less specimen volume (Photo courtesy of ARUP Laboratories)

Spectral Flow Cytometry Assay Enhances MRD Detection in Multiple Myeloma

imal residual disease (MRD) monitoring is pivotal in multiple myeloma, where persistent malignant plasma cells drive relapse risk and help guide therapy decisions. In the United States, approximately 202,000... Read more

Immunology

view channel
Ultrasensitive Blood Test Detects Sjögren’s Signature Years Before Diagnosis
New Assays Expand Cytokine Testing for Transplant and Immunocompromised Patients
Cell-Free Assay Detects Functional IgE for Food Allergy Diagnosis
Image: New findings show unique pathogen‑directed antibody patterns are already present years ahead of a formal diagnosis of inflammatory bowel disease (Image Credit: iStock)

Antibody Profiling Identifies Preclinical Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease often develops after a prolonged symptom-free period, complicating timely recognition and clinical intervention. Limited understanding of immune activity during this silent phase... Read more

Microbiology

view channel
Syndromic GI Panel Detects Cyclospora for Rapid Case Confirmation
Rapid Panel Identifies Gram-Negative Pathogens and Resistance Markers in Bloodstream...
Bacterial Growth Assay Predicts COVID-19 Severity From Plasma
Image: The second‑generation assay detects all four Ebola viruses known to cause human disease: Bundibugyo, Zaire, Sudan, and Taï Forest (Image Credit: Adobe Stock)

New Rapid Ebola Antigen Test Detects Infection at Point of Care

A serious Ebola epidemic centered in the Democratic Republic of the Congo has caused hundreds of deaths and triggered a global public health emergency, with cases also reported in Uganda.... Read more

Pathology

view channel
AI Bone Marrow Mapping Provides New Tool to Track Blood Cancer Severity
Imaging Platform Maps Lipid Accumulations in Fabry Heart Tissue
AI Tissue Imaging Helps Guide Targeted Therapy for Lung Cancer
Multiplex immunofluorescent (left) and H&E-stained (right) breast tumor samples illustrating high versus low Base Topology Scores. Higher topology scores reflect more organized tissue architecture, while lower scores indicate greater structural disorganization. By quantitatively measuring these structural differences, the researchers developed biomarkers that predicted patient outcomes more accurately than many traditional approaches. (Photo courtesy of Columbia University Irving Medical Center)

Digital Pathology Tool Predicts Breast Cancer Outcomes and Therapy Response

Breast cancer prognosis often depends on microscopic assessment of tumor architecture, a process that can be subjective and lead to variable predictions across patient groups. Quantitative measures that... Read more

Technology

view channel
New CE-Certified Software Advances Whole-Genome Cancer Testing
National Rare Disease Registry Standardizes Genetic and Clinical Data for Coordi...
AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
Image Credit: Adobe Stock

Training Device Improves Accuracy of Pooled Molecular Diagnostics

High-throughput molecular diagnostics have transformed infectious disease detection, but many workflows remain difficult to execute accurately without extensive training. Sample pooling can cut per‑test... Read more

Industry

view channel
Tempus to Acquire Personalis in $1.5 Billion Precision Oncology Deal
Bruker Expands NGS Capabilities for Sepsis and Bloodstream Infections
Leica Biosystems to Expand Pathology Portfolio Through StatLab Acquisition
Image: Extracellular vesicles offer a noninvasive way to access meaningful brain signals from a small blood sample (Image Credit: Shutterstock)

Collaboration Advances Extracellular Vesicle-Based Tests for Neurodegenerative Diseases

NanoSomiX, Inc. and Beckman Coulter Diagnostics announced a collaboration to explore the development of next-generation immunoassays for neurodegenerative diseases using extracellular vesicles (EVs).... Read more
Copyright © 2000 - 2026 Globetech Media.
All rights reserved.
PURITAN MEDICAL